CD209 and infection: Taken together, our results demonstrated that B8-dIgA1- and B8-dIgA2-mediated SARS-CoV-2 infection likely involved viral capture and infection of mucosal CD209+ cells, followed by more robust trans-infection of ACE2+ epithelial cells through cell–cell transmission in NT.